Dow Down 0.16% Nasdaq Down 0.29%

Immunomedics Inc. (IMMU)

-NGM
3.75 Down 0.09(2.34%) 2:08PM EDT - Nasdaq Real Time Price
Prev Close:3.84
Open:3.76
Bid:3.77 x 7100
Ask:3.78 x 3600
1y Target Est:6.75
Beta:0.71
Next Earnings Date:N/A
Day's Range:3.69 - 3.99
52wk Range:3.04 - 7.35
Volume:1,075,211
Avg Vol (3m):526,364
Market Cap:349.18M
P/E (ttm):N/A
EPS (ttm):-0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMMU

Comparison

Symbol% ChgMkt Cap
IMMUDown 2.34%349.18M
BIIBDown 0.03%77.94B
GSKDown 0.49%110.65B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):39.55
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.48
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback